Keep track of the rapidly evolving world of genetically informed cancer medicine and targeted therapies with this app, brought to you by MyCancerGenome.org. The My Cancer Genome (short name MCG) app provides information on cancer types, cancer-related genes, and specific cancer-related genetic mutations. In addition, the app provides information on the drug classes, drug targets, and drug names for antineoplastic agents, either FDA-approved or being studied in clinical trials.

FEATURES
•Search for information by cancer type, gene, or specific mutation
•Search for specific drugs by development name, generic name, or trade name
•Find groups of mutations by cancer type, gene, or mutation – for example, see a list of all cancer types in which the gene BRAF is important
•Find groups of drugs by drug class or drug target
•Save favorite searches and pages of interest so that you can quickly check for updates
•Read information about genetically informed cancer medicine, including about how mutations are detected and the different types of targeted therapies available

FREQUENTLY ASKED QUESTIONS

How often is the MCG app updated?

The information in the app is routinely updated by the My Cancer Genome staff and contributors. It is updated in your mobile app when you open the mobile app or refresh the content.

Will more MyCancerGenome.org content and the clinical trials search be included in future releases of the mobile app?

We are always adding new drug, disease, gene, and mutation-related content to the app. We hope to continue to add features to the My Cancer Genome mobile app in the future, as well. Please let us know how the mobile app helps you and which features would enhance your use of the mobile app by filling out our survey.

ABOUT MYCANCERGENOME.ORG

The My Cancer Genome (MCG) app is brought to you by the team that created MyCancerGenome.org. My Cancer Genome has won the National Cancer Institute and Office of the National Coordinator for Health Information Technology’s “Using Public Data for Cancer Prevention and Control: From Innovation to Impact” Developer Challenge and the GE Healthymagination Innovation Challenge. It was featured as one of “7 consumer, big data healthcare apps that you should know about” by MedCity News, and it was featured in the NYT article by Anne Eisenberg, “Variations on a gene, and tools to find them.”

Genetically informed cancer medicine is becoming the next standard of care. Evidence regarding the clinical significance of tumor gene mutations for predicting response to cancer treatments is evolving at a rate that outpaces traditional approaches to knowledge dissemination. To enable this promising approach, Dr. William Pao and Dr. Mia Levy of Vanderbilt University launched My Cancer Genome (MCG) in January 2011 as the nation's first precision cancer medicine knowledge resource.

MCG provides up-to-date information on mutation-specific treatments and clinical trials. As of April 2014, content covers 400 mutations in 19 cancer types. Physicians and physician–scientists from 22 institutions in 10 countries contribute content to MCG. My Cancer Genome includes a clinical trial search covering more than 37,000 cancer clinical trials, annotated with information about more than 500 cancer-related genes. My Cancer Genome also houses the DIRECT database, which provides information on outcomes of patients with EGFR mutations in lung cancer. Finally, My Cancer Genome houses a list of targeted therapeutics, either FDA approved or in clinical development.